Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127846111 | 12784611 | 1 | I | 20160706 | 20160919 | 20160927 | 20160927 | EXP | GB-MHRA-EYC 00145234 | PHHY2016GB129339 | SANDOZ | 48.00 | YR | M | Y | 63.00000 | KG | 20160927 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127846111 | 12784611 | 1 | PS | BISOPROLOL FUMARATE. | BISOPROLOL FUMARATE | 1 | Oral | 5 MG, UNK | GA0180 | 75643 | 5 | MG | |||||||
| 127846111 | 12784611 | 2 | I | DIAMICRON | GLICLAZIDE | 1 | Oral | 30 MG, UNK | 224623 | 0 | 30 | MG | |||||||
| 127846111 | 12784611 | 3 | I | ALCOHOL. | ALCOHOL | 1 | Unknown | 5 PINTS. LAGER | U | 0 | |||||||||
| 127846111 | 12784611 | 4 | C | ASPIRIN//ACETYLSALICYLIC ACID | ASPIRIN | 1 | Unknown | U | 0 | ||||||||||
| 127846111 | 12784611 | 5 | C | GLYCERYL TRINITRATE | NITROGLYCERIN | 1 | Unknown | U | 0 | ||||||||||
| 127846111 | 12784611 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 127846111 | 12784611 | 7 | C | PRASUGREL | PRASUGREL | 1 | Unknown | U | 0 | ||||||||||
| 127846111 | 12784611 | 8 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | U | 0 | ||||||||||
| 127846111 | 12784611 | 9 | C | ROSUVASTATIN. | ROSUVASTATIN | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127846111 | 12784611 | 1 | Myocardial infarction |
| 127846111 | 12784611 | 2 | Type 2 diabetes mellitus |
| 127846111 | 12784611 | 3 | Product used for unknown indication |
| 127846111 | 12784611 | 4 | Product used for unknown indication |
| 127846111 | 12784611 | 5 | Product used for unknown indication |
| 127846111 | 12784611 | 6 | Product used for unknown indication |
| 127846111 | 12784611 | 7 | Product used for unknown indication |
| 127846111 | 12784611 | 8 | Product used for unknown indication |
| 127846111 | 12784611 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127846111 | 12784611 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127846111 | 12784611 | Aggression | |
| 127846111 | 12784611 | Alcohol interaction | |
| 127846111 | 12784611 | Amnesia | |
| 127846111 | 12784611 | Burning sensation | |
| 127846111 | 12784611 | Lethargy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127846111 | 12784611 | 1 | 20160224 | 0 | ||
| 127846111 | 12784611 | 2 | 20160705 | 0 |